Epidrugs: targeting epigenetic marks in cancer treatment

Jaclyn L Congress, Erwin C Wang, Christopher J Shoff, Mark B Leick, G Ian Gallicano, Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer. Journal of stem cells. ,vol. 1, pp. 59- 74 ,(2012)

Michael C. Haffner, Alcides Chaux, Alan K. Meeker, David M. Esopi, Jonathan Gerber, Laxmi G. Pellakuru, Antoun Toubaji, Pedram Argani, Christine Iacobuzio-Donahue, William G. Nelson, George J. Netto, Angelo M. De Marzo, Srinivasan Yegnasubramanian, Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers Oncotarget. ,vol. 2, pp. 627- 637 ,(2011) , 10.18632/ONCOTARGET.316

Peter A. Jones, Stephen B. Baylin, The fundamental role of epigenetic events in cancer Nature Reviews Genetics. ,vol. 3, pp. 415- 428 ,(2002) , 10.1038/NRG816

Eunhee Kim, Janine O. Ilagan, Yang Liang, Gerrit M. Daubner, Stanley C.-W. Lee, Aravind Ramakrishnan, Yue Li, Young Rock Chung, Jean-Baptiste Micol, Michele E. Murphy, Hana Cho, Min-Kyung Kim, Ahmad S. Zebari, Shlomzion Aumann, Christopher Y. Park, Silvia Buonamici, Peter G. Smith, H. Joachim Deeg, Camille Lobry, Iannis Aifantis, Yorgo Modis, Frederic H.-T. Allain, Stephanie Halene, Robert K. Bradley, Omar Abdel-Wahab, SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition Cancer Cell. ,vol. 27, pp. 617- 630 ,(2015) , 10.1016/J.CCELL.2015.04.006

Olga Grishina, Claudia Schmoor, Konstanze Döhner, Björn Hackanson, Beate Lubrich, Annette M. May, Caroline Cieslik, Michael J. Müller, Michael Lübbert, DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy BMC Cancer. ,vol. 15, pp. 430- 430 ,(2015) , 10.1186/S12885-015-1432-5

Chang Xia, Roberto Leon-Ferre, Douglas Laux, Jeremy Deutsch, Brian J. Smith, Melanie Frees, Mohammed Milhem, Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide) Cancer Chemotherapy and Pharmacology. ,vol. 74, pp. 691- 697 ,(2014) , 10.1007/S00280-014-2501-1

Oscar Alcazar, Susan Achberger, Wayne Aldrich, Zhenbo Hu, Soledad Negrotto, Yogen Saunthararajah, Pierre Triozzi, Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo International Journal of Cancer. ,vol. 131, pp. 18- 29 ,(2012) , 10.1002/IJC.26320

Karin Buiting, Prader-Willi syndrome and Angelman syndrome American Journal of Medical Genetics Part C: Seminars in Medical Genetics. ,vol. 154C, pp. 365- 376 ,(2010) , 10.1002/AJMG.C.30273

Oliver Müller, Nick Kepper, Robert Schöpflin, Ramona Ettig, Karsten Rippe, Gero Wedemann, Changing chromatin fiber conformation by nucleosome repositioning. Biophysical Journal. ,vol. 107, pp. 2141- 2150 ,(2014) , 10.1016/J.BPJ.2014.09.026

Teresa K. Barth, Axel Imhof, Fast signals and slow marks: the dynamics of histone modifications Trends in Biochemical Sciences. ,vol. 35, pp. 618- 626 ,(2010) , 10.1016/J.TIBS.2010.05.006